← FDA Drug Approvals (Drugs@FDA)
FINASTERIDE AND TADALAFIL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS LIFESCIENCES · Approved 2024-03-15
Drug application
- FDA Application #
ANDA218232- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- FINASTERIDE AND TADALAFIL
- Generic name
- Finasteride
- Active ingredients
- FINASTERIDE; TADALAFIL
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- ZYDUS LIFESCIENCES
- First approval
- 2024-03-15
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown